skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: any thoughts on the current run in espial? seems the timing of it coincides with rogers announcement of a new hdr 4k service starting soon

thanks
Read Answer Asked by michael on October 06, 2015
Q: Could you define for me what period of time you are meaning when you say "Long Term, Mid Term and Short Term" ...
and THANK YOU for keeping us on an even track during this turmoil !!
Read Answer Asked by Alexandra on October 06, 2015
Q: Can you provide an update analysis on bird bdt and canwell as an investment for dividends and moderate growth? Are both dividends sustainable based on coverage ratios or do you prefer one over the other? Thanks again! John.
Read Answer Asked by john on October 06, 2015
Q: What is your opinion of and advice on public vs. private apartment rental REITs like Centurion Apartment.

Read Answer Asked by Jean on October 06, 2015
Q: Given the trade deal that was signed today would you have any sector-stock selections that could benefit. What would you recommend for a protein stock. sap, hlf, Clearwater or mapleleaf.
Thank you as always.
Chris
Read Answer Asked by chris on October 06, 2015
Q: I have $12000 that i would like to invest a company bond any suggestions
Read Answer Asked by Pierre on October 06, 2015
Q: Any reason for today's decline and is this an opportunity to add to my position ... My average cost here is 18.50
Read Answer Asked by Bob on October 06, 2015
Q: Yesterday, Gord said that BEP.UN in his unregistered account causes problems every year when he files his returns with CRA. What would those problems be?
Read Answer Asked by chris on October 06, 2015
Q: Hi Peter & team, Since Sept. 2, WIN has entered into 9 patent license agreements. The settlement and terms of the license agreements, as usual, are confidential. One would think the stock would do better. Your comments pls.
Silvia
Read Answer Asked by Silvia on October 06, 2015
Q: Hello,

I have this dogs and sitting on them for a year and they don't go anywhere. I'm thinking of selling them for tax purposes. The question is do they represent value and buy them back in 30 days or buy something else now that have better momentum?
If you have 200k, would you deploy it now or sit tight until market gets some direction. If now what would you pick.

Thank you
M
Read Answer Asked by Marios on October 06, 2015
Q: Hi team,
for tax purposes I need to sell 3 of these 6 names: ATH, BAD, BNK, GS, MRC and RMP. Which 3 you'll recomend to sell and buy in 30 days or can you give me 3 other names to make a swich now or later. in which 3 of them you see more upside potential?

regards,
Read Answer Asked by Nick on October 06, 2015
Q: Is it time to buy first quantum and tech resources?
Read Answer Asked by Helen on October 06, 2015
Q: Hi I still own some Canexus. What do you recommend with the Superior Plus offer? Sell, take the Superior Plus shares and hold them or sell them?
Thanks
Read Answer Asked by Francois on October 06, 2015
Q: Could you give me your take on the two press releases posted yesterday (new CEO and ammonia problem). Do you think RMX will have to raise more capital to fund improvements with mill/tailing pond?? I haven't been able to reach RMX IR so asking you!! I put in a stink bid yesterday and got filled at 60 cents but I'm having second thoughts now.
Read Answer Asked by Ralph on October 06, 2015
Q: In response to Terry's question on the sudden drop in EIF, there is a new issue this morning at $24.40 per share.... which quickly sold out. Hence the drop in price.
Read Answer Asked by Paul W on October 06, 2015
Q: Hi, Peter For info only, publish at will
Another reason Health Care was weak Monday, was the passing of the TPP (or Trans Pacific Patrnership), which according to The Hill, a Beltway newsletter which provides daily updates,

” Trade officials from 12 countries agreed Monday to shrink the length of time that pharmaceutical companies can receive monopoly rights for certain drugs, a provision that is already threatening to incite a Big pharma rebellion on Capitol Hill…Brand-name companies would receive up to eight years of monopoly rights for drugs known as biologics — a decrease from the current 12 years provided under U.S. law, according to officials involved. The final language of the deal has not yet been released.”
Read Answer Asked by claude on October 06, 2015
Q: Could I please have your comments on ORT. It is starting commissioning shortly or has already started. It received a patent approval recently. Is it time to take a position in this stock? Thanks.
Read Answer Asked by Bruce on October 06, 2015